Bristol-Myers Squibb Company PFD CONV 2
General ticker "BMYMP" information:
- Sector: Health Care
- Industry: Drug Manufacturers - General
- Capitalization: $103.6B (TTM average)
Bristol-Myers Squibb Company PFD CONV 2 does not follow the US Stock Market performance with the rate: -30.1%.
Estimated limits based on current volatility of 1.1%: low 884.79$, high 904.27$
Factors to consider:
- Company pays dividends (quarterly): last record date 2025-11-04, amount 0.50$ (Y0.22%)
- Total employees count: 34300 as of 2022
- US accounted for 70.6% of revenue in the fiscal year ended 2024-12-31
Short-term BMYMP quotes
Long-term BMYMP plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $46,159.00MM | $45,006.00MM | $48,300.00MM |
| Operating Expenses | $36,888.00MM | $36,534.00MM | $38,642.00MM |
| Operating Income | $9,271.00MM | $8,472.00MM | $9,658.00MM |
| Non-Operating Income | $-1,558.00MM | $-32.00MM | $-18,037.00MM |
| Interest Expense | $1,232.00MM | $1,166.00MM | $1,947.00MM |
| R&D Expense | $9,411.00MM | $9,207.00MM | $9,782.00MM |
| Income(Loss) | $7,713.00MM | $8,440.00MM | $-8,379.00MM |
| Taxes | $1,368.00MM | $400.00MM | $554.00MM |
| Profit(Loss)* | $6,327.00MM | $8,025.00MM | $-8,948.00MM |
| Stockholders Equity | $31,061.00MM | $29,430.00MM | $16,335.00MM |
| Inventory | $2,339.00MM | $2,662.00MM | $2,557.00MM |
| Assets | $96,820.00MM | $95,159.00MM | $92,603.00MM |
| Operating Cash Flow | $13,066.00MM | $13,860.00MM | $15,190.00MM |
| Capital expenditure | $1,118.00MM | $1,209.00MM | $1,248.00MM |
| Investing Cash Flow | $-1,062.00MM | $-2,295.00MM | $-21,352.00MM |
| Financing Cash Flow | $-16,962.00MM | $-9,416.00MM | $5,127.00MM |
| Earnings Per Share** | $2.97 | $3.88 | $-4.41 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.